Real-time enrollment status for this metastatic breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:32 PM UTC
| NCT Number | NCT06795529 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 400 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | November 18, 2025 (Nov 18, 2025) |
As of July 13, 2026: Clinical trial NCT06795529 is currently recruiting participants. This clinical trial study for metastatic breast cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06795529 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06795529 was last updated Nov 18, 2025 (November 18, 2025). HelloStudys verifies this status automatically.